{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:07:17Z","timestamp":1768709237369,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005452","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000},"record-id":"33461"},{"DOI":"10.1002\/14651858.cd005452","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000}}],"reference-count":55,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005452.pub2","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T22:44:54Z","timestamp":1299710694000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gabapentin for acute and chronic pain"],"prefix":"10.1002","volume":"2019","author":[{"given":"Philip J","family":"Wiffen","sequence":"first","affiliation":[{"name":"Thame UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J","family":"McQuay","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); West Wing (Level 6) John Radcliffe Hospital Oxford Oxfordshire UK OX3 9DU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayne","family":"Edwards","sequence":"additional","affiliation":[{"name":"UK Cochrane Centre; Training Team; National Institute for Health Research Summertown Pavilion, Middle Way Oxford UK OX2 7LG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,16]]},"reference":[{"key":"10.1002\/14651858.CD005452.pub2-BIB2|cit1","doi-asserted-by":"crossref","first-page":"Suppl 6:S57-9","DOI":"10.1111\/j.1528-1157.1999.tb00934.x","article-title":"Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus","volume":"40","author":"Backonja","year":"1999","journal-title":"Epilepsia"},{"issue":"21","key":"10.1002\/14651858.CD005452.pub2-BIB1|cit2","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with Diabetes Mellitus","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD005452.pub2-BIB3|cit3","first-page":"481","article-title":"Gabapentin in postamputation phantom limb pain: a randomized, double blind, placebo controlled, cross-over study","volume":"27","author":"Bone","year":"2002","journal-title":"Regional Anesthesia and Pain Medicine"},{"issue":"14","key":"10.1002\/14651858.CD005452.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","article-title":"Gabapentin for neuropathic cancer pain: A randomized controlled trial from the Gabapentin Cancer Pain Study Group","volume":"22","author":"Caraceni","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD005452.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0885-3924(00)00181-0","article-title":"Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study","volume":"20","author":"Dallocchio","year":"2000","journal-title":"Journal of Pain and Symptom Management"},{"issue":"3","key":"10.1002\/14651858.CD005452.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00000542-200209000-00007","article-title":"A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy","volume":"97","author":"Dirks","year":"2002","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD005452.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jnnp.66.2.251","article-title":"Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial","volume":"66","author":"Gorson","year":"1999","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"16","key":"10.1002\/14651858.CD005452.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","article-title":"Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain","volume":"159","author":"Morello","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD005452.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/00000539-200212000-00046","article-title":"Gabapentin for the treatment of pain in Guillain-Barre syndrome: a double blind, placebo controlled, crossover study","volume":"95","author":"Pandey","year":"2002","journal-title":"Anesthesia and Analgesia"},{"issue":"8","key":"10.1002\/14651858.CD005452.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9343(00)00398-3","article-title":"Gabapentin therapy for diabetic neuropathic pain [letter]","volume":"108","author":"Perez","year":"2000","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005452.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"issue":"21","key":"10.1002\/14651858.CD005452.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD005452.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0304-3959(02)00255-5","article-title":"Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial","volume":"99","author":"Serpell","year":"2002","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD005452.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00131402-200112000-00002","article-title":"Gabapentin and Venlafaxine for the treatment of painful diabetic neuropathy","volume":"3","author":"Simpson","year":"2001","journal-title":"Journal of Clinical Neuromuscular Disease"},{"issue":"2","key":"10.1002\/14651858.CD005452.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10790268.2002.11753609","article-title":"Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized,double-blind, crossover trial","volume":"25","author":"Tai","year":"2002","journal-title":"The Journal of Spinal Cord Medicine"},{"key":"10.1002\/14651858.CD005452.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000007979","article-title":"Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: A pilot study","volume":"40","author":"Attal","year":"1998","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD005452.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/0269216304pm845ra","article-title":"Gabapentin in the treatment of neuropathic pain","volume":"18","author":"Bennett","year":"2004","journal-title":"Palliative Medicine"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD005452.pub2-BIB18|cit18","first-page":"S51-6; discussi","article-title":"Postherpetic neuralgia: role of gabapentin and other treatment modalities. [Review] [51 refs]","volume":"40","author":"Beydoun","year":"1999","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005452.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1525-5050(02)00017-3","article-title":"Clinical use of tricyclic anticonvulsants in painful neuropathies and bipolar disorders","volume":"3","author":"Beydoun","year":"2002","journal-title":"Epilepsy and Behaviour"},{"key":"10.1002\/14651858.CD005452.pub2-BIB20|cit20","first-page":"129","article-title":"Anticonvulsants for the management of pain","volume":"7","author":"Chong","year":"2000","journal-title":"Pain Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005452.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0003-9993(00)90135-7","article-title":"Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial","volume":"81","author":"Cutter","year":"2000","journal-title":"Archives of Physical Medicine & Rehabilitation"},{"issue":"Suppl4","key":"10.1002\/14651858.CD005452.pub2-BIB22|cit22","first-page":"A378","article-title":"Gabapentin for pain associated with diabetic peripheral neuropathy. A double blind, placebo controlled study (945-2100)","volume":"50","author":"Edwards","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD005452.pub2-BIB23|cit23","first-page":"A203 (Suppl 2)","article-title":"Gabapentin versus carbamazepine in conservative management of carpel tunnel syndrome","volume":"52","author":"Facchetti","year":"1999","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD005452.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archinte.160.7.1040","article-title":"Gabapentin vs amitriptyline for the treatment of peripheral neuropathy","volume":"160","author":"Fudin","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005452.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00000542-200209000-00004","article-title":"Is gabapentin a \"Broad-spectrum\" analgesic?","volume":"97","author":"Gilron","year":"2002","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1002\/14651858.CD005452.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.sc.3100481","article-title":"Gabapentin for the treatment of spasticity in patients with spinal cord injury","volume":"35","author":"Gruenthal","year":"1997","journal-title":"Spinal Cord"},{"issue":"4","key":"10.1002\/14651858.CD005452.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0149-2918(01)80058-8","article-title":"Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy","volume":"23","author":"Hemstreet","year":"2001","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD005452.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/135245859700300407","article-title":"Open label gabapentin treatment for pain in multiple sclerosis","volume":"3","author":"Houtchens","year":"1997","journal-title":"Multiple Sclerosis"},{"issue":"Suppl A","key":"10.1002\/14651858.CD005452.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/eujp.2001.0324","article-title":"Anticonvulsants in neuropathic pain: rationale and clinical evidence","volume":"6","author":"Jensen","year":"2002","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD005452.pub2-BIB30|cit30","first-page":"S66-72; discuss","article-title":"Nonepileptic uses of gabapentin","volume":"40 Suppl 6","author":"Magnus","year":"1999","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD005452.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00002508-200112000-00002","article-title":"Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature","volume":"17","author":"Mellegers","year":"2001","journal-title":"Clinical Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD005452.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.47.6.1383","article-title":"Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis","volume":"47","author":"Miller","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD005452.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0003-9993(97)90168-4","article-title":"Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis","volume":"78","author":"Mueller","year":"1997","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"4","key":"10.1002\/14651858.CD005452.pub2-BIB34|cit34","first-page":"185","article-title":"Low dose gabapentin for shoulder-hand syndrome induced by phenobarbital: a three-month study","volume":"25","author":"Rovetta","year":"1999","journal-title":"Drugs Under Experiment and Clinical Research"},{"issue":"3","key":"10.1002\/14651858.CD005452.pub2-BIB35|cit35","first-page":"173","article-title":"Gabapentin for painful diabetic neuropathy","volume":"48","author":"Seidl","year":"1999","journal-title":"The Journal of Family Practice"},{"issue":"3","key":"10.1002\/14651858.CD005452.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD005452.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000008192","article-title":"Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis","volume":"44","author":"Solaro","year":"2000","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD005452.pub2-BIB38|cit38","first-page":"P-307 E","article-title":"Study of gabapentin in neuropathic pain syndromes","volume":"32","author":"Steinmetz","year":"1997","journal-title":"ASHP mid year clinical meeting"},{"issue":"5","key":"10.1002\/14651858.CD005452.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200060050-00005","article-title":"Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy","volume":"60","author":"Tremont-Lukats","year":"2000","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD005452.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1163\/156856903767650718","article-title":"The effectiveness of gabapentin in patients with chronic radiculopathy","volume":"15","author":"Yildirim","year":"2003","journal-title":"The Pain Clinic"},{"key":"10.1002\/14651858.CD005452.pub2-BIB41|cit41","unstructured":"Anticonvulsants: Pfizers pregabalin to top success of Neuronytin? Webpage: www.bioportfolio.com\/news\/datamonitor_38.htm"},{"key":"10.1002\/14651858.CD005452.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005452.pub2-BIB43|cit43","volume-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","author":"Grahame-Smith","year":"1992"},{"key":"10.1002\/14651858.CD005452.pub2-BIB44|cit44","unstructured":"Jacox A Carr DB Payne R Management of cancer pain. Clinical Practice Guideline No. 9. Agency for Health Care Policy and Research Rockville, Maryland US Department of Health and Human Services, Public Health Service"},{"key":"10.1002\/14651858.CD005452.pub2-BIB45|cit45","volume-title":"Meta-analysis of randomised clinical trials in pain relief [DPhil thesis]","author":"Jadad-Bechara","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD005452.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005452.pub2-BIB47|cit47","volume-title":"An evidence-based resource for pain relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD005452.pub2-BIB48|cit48","first-page":"963","article-title":"Psychotropic drugs","volume-title":"Textbook of Pain","author":"Monks","year":"1994"},{"key":"10.1002\/14651858.CD005452.pub2-BIB49|cit49","first-page":"436","article-title":"Drugs effective in the therapy of the epilepsies","volume-title":"The pharmacological basis of therapeutics","author":"Rall","year":"1992"},{"key":"10.1002\/14651858.CD005452.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005452.pub2-BIB51|cit51","first-page":"353","volume-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2005"},{"issue":"3","key":"10.1002\/14651858.CD005452.pub2-BIB52|cit52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001133","article-title":"Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005452.pub2-BIB53|cit53","article-title":"Carbamazepine for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005452.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: aetiology,symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD005452.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005452.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T18:08:20Z","timestamp":1699985300000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005452.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,16]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005452.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,16]]}}}